GHK-Cu (Copper Peptide) for Skin Regeneration — Skin & Hair
Tripeptide-copper complex with wound healing, collagen synthesis, and anti-aging properties; moderate evidence for topical skin rejuvenation.
Overview
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide with high affinity for copper(II) ions, first isolated from human plasma in 1973 by Loren Pickart. Plasma GHK-Cu levels decline from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, paralleling the decline in tissue repair capacity. GHK-Cu exerts its biological effects through multiple mechanisms: it stimulates collagen I, III, and elastin synthesis in dermal fibroblasts, promotes glycosaminoglycan (decorin, dermatan sulfate) production, enhances angiogenesis via VEGF upregulation, and activates metalloproteinase remodeling for scar-free wound healing. The copper ion is essential for lysyl oxidase activity, which cross-links collagen and elastin fibers for structural integrity. In clinical studies, topical GHK-Cu creams have demonstrated improvements in skin thickness, elasticity, firmness, and reduction of fine lines comparable to tretinoin but with better tolerability. Wound healing studies show accelerated closure of surgical wounds and diabetic ulcers. Gene expression analysis reveals that GHK-Cu modulates over 4,000 human genes, with a net effect of resetting gene expression patterns toward a younger profile. Injectable and topical formulations are used in aesthetic medicine, though most robust clinical evidence pertains to topical application.
Indications
- Moderate evidence: Topical skin rejuvenation and anti-aging (wrinkle reduction, firmness)
- Moderate evidence: Wound healing acceleration (surgical wounds, minor burns)
- Moderate evidence: Hair growth stimulation (follicle enlargement)
- Emerging evidence: Post-procedure skin recovery (laser, microneedling)
- Preclinical: Anti-inflammatory and antioxidant gene expression modulation
- Off-label: Injectable for systemic tissue repair (limited clinical data)
Mechanism of Action
GHK binds copper(II) ions with high affinity and delivers them to cells, activating copper-dependent enzymes including lysyl oxidase and superoxide dismutase
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| GHK-Cu cream/serum | 1-2% concentration | Once or twice daily | Most studied topical formulation; apply to clean skin |
| GHK-Cu serum | 0.5-1 mL of 0.01% solution | Per microneedling session | Applied during microneedling for enhanced penetration |
| GHK-Cu injectable | 200-500 mcg | Once daily | Off-label injectable use; limited clinical data |
Evidence Grade
GRADE C
Safety & Contraindications
- Topical application is well tolerated with minimal irritation in clinical studies
- Copper sensitivity or allergy is rare but should be screened
- Wilson disease patients should avoid due to copper accumulation risk
- Injectable use lacks robust safety data — off-label with limited controlled trials
- Do not apply to actively infected wounds
- Pregnancy/lactation safety not established for injectable forms